Tag: United States
Biocon Biologics obtains US-FDA approval for biosimilar Aflibercept for Yesafili
A significant milestone for the company marking its entry into ophthalmology, a new therapeutic area in the United States
In a first, Amul to produce & launch its fresh milk...
This partnership between the two cooperatives will bring the Amul to millions of Americans through its branded fresh milk products in the United States using MMPA's superior technology
Cipla enters into JV with Kemwell Biopharma & Manipal Education &...
The primary goal of this joint venture is to develop and commercialize novel Cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Biocon Biologics launches biosimilar ‘Hulio’ in USA
HULIO® (adalimumab-fkjp) injection, a biosimilar to Humira® (adalimumab) has been introduced in the United States after five years of experience in Europe and two years in Canada.
AMPATH launches its pathology laboratory in Mumbai
The lab has collaborated with UPMC, one of the top ranked hospitals in the United States, which allows them to work with the world’s leading clinicians to help them ensure customers comprehensive services that reflect precision and accuracy in every test conducted..........................
Bharat Biotech clarifies on the US-FDA’s EUA denial for COVAXIN
As per Bharat Biotech, its US partner, Ocugen has received a recommendation from the FDA to pursue Biologics License Applications (BLA) path for COVAXIN, which is full approval instead of EUA...................
Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules...
A calcineurin inhibitor, Tacrolimus has been particularly effective in treating patients of renal transplant for more than two decades..............
Piramal Pharma Solutions invests $10 million to expand its API ...
The enhanced capability opens the Michigan site up to a new base of customers, including the antibody drug conjugate (ADC) market.............................
US-China trade war offers window of opportunity for Indian pharma sector
As per the leading data and analytics company GlobalData, the standoff between China and India over regulatory issues provides great opportunity for the Indian pharma firms to penetrate the Chinese healthcare market and reduce trade deficit...………..
Indian researcher led US team finds a new mechanism key to...
The team led by Dr Gunjan Arora, Postdoctoral Fellow at the National Institute of Allergy and Infectious Diseases in the United States has discovered a new mechanism that could be exploited in the mission to create a malaria vaccine..............